NewsCompanies roundup: NatWest, Darktrace & a Google dividendNews and updates on your investmentsSave26 April 2024
NewsAnglo American rejects BHP's 拢31bn bidThe structure of the deal has been highlighted in addition to the perceived valuation shortfallSave26 April 2024
NewsWeight-loss drugmakers race to prove health benefitsWinning market share is increasingly a matter of showing insurers and regulators that GLP-1s really are miracle drugs Save26 April 2024
Small Companies & AIMBack this highly defensive petcare small capThe Aim-traded group offers exposure to the veterinary sector 鈥 without the regulatory woes of its largest rivalsSave25 April 2024
Special ReportsProfessional investors' biggest mistakes 鈥 and how to avoid themStockpicking requires nouse and emotional intelligence 鈥 fund managers share their five best lessons from a lifetime of investingSave25 April 2024
NewsSainsbury's expects operating profit growth as volumes riseSome evidence of trading up came through in the resultsSave25 April 2024
NewsAstraZeneca鈥檚 cancer drugs drive big earnings beatAfter a period of uncertainty, and a very public executive pay row, the UK鈥檚 biggest pharma group is back on trackSave25 April 2024
NewsUnilever reports encouraging volume growthThe strength of its core brands support the group's 鈥淕rowth Action Plan鈥Save25 April 2024
EconomicsToday's markets: Big hitters push up the FTSEUpdates on world markets and companies newsSave25 April 2024
NewsBHP proposes 拢31bn Anglo American buyoutWeakness in Anglo's share price opens the door for the Australian giant to take out its copper, iron ore and met coal assetsSave25 April 2024